Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.
Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, Comberiati P, Apfelbacher C, Genuneit J, Avdeev S, Kapustina V, Guekht A, Fomin V, Svistunov AA, Timashev P, Subbot VS, Royuk VV, Drake TM, Hanson SW, Merson L, Carson G, Horby P, Sigfrid L, Scott JT, Semple MG, Warner JO, Vos T, Olliaro P, Glybochko P, Butnaru D; Sechenov StopCOVID Research Team.
Munblit D, et al. Among authors: hanson sw.
Clin Exp Allergy. 2021 Sep;51(9):1107-1120. doi: 10.1111/cea.13997. Epub 2021 Aug 12.
Clin Exp Allergy. 2021.
PMID: 34351016
Free PMC article.
Clinical Trial.
BACKGROUND: The long-term sequalae of COVID-19 remain poorly characterized. We assessed persistent symptoms in previously hospitalized patients with COVID-19 and assessed potential risk factors. ...Participants were interviewed via telephone using an ISARIC Long-term …
BACKGROUND: The long-term sequalae of COVID-19 remain poorly characterized. We assessed persistent symptoms in previously hospitalize …